| Sign In to gain access to subscriptions and/or personal tools. |
Retinal nerve fiber thickness in inflammatory demyelinating diseases of childhood onsetPediatric Multiple Sclerosis Center, State University of New York at Buffalo, Buffalo, New York, USA; Departments of Neurology, State University of New York at Buffalo, Buffalo, New York, USA
Pediatric Multiple Sclerosis Center, State University of New York at Buffalo, Buffalo, New York, USA; Departments of Neurology, State University of New York at Buffalo, Buffalo, New York, USAbguttman{at}thejni.org
Ross Eye Institute, State University of New York at Buffalo, Buffalo, New York, USA; Ophthalmology, State University of New York at Buffalo, Buffalo, New York, USA
Ross Eye Institute, State University of New York at Buffalo, Buffalo, New York, USA; Ophthalmology, State University of New York at Buffalo, Buffalo, New York, USA
Departments of Neurology, State University of New York at Buffalo, Buffalo, New York, USA
Pediatric Multiple Sclerosis Center, State University of New York at Buffalo, Buffalo, New York, USA
Pediatric Multiple Sclerosis Center, State University of New York at Buffalo, Buffalo, New York, USA; Departments of Neurology, State University of New York at Buffalo, Buffalo, New York, USA
Ross Eye Institute, State University of New York at Buffalo, Buffalo, New York, USA; Ophthalmology, State University of New York at Buffalo, Buffalo, New York, USA
Pediatric Multiple Sclerosis Center, State University of New York at Buffalo, Buffalo, New York, USA; Departments of Neurology, State University of New York at Buffalo, Buffalo, New York, USA
Pediatric Multiple Sclerosis Center, State University of New York at Buffalo, Buffalo, New York, USA; Departments of Neurology, State University of New York at Buffalo, Buffalo, New York, USA; Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, New York, USA Purpose To evaluate retinal nerve fiber layer thickness (RNFLT) using optical coherence tomography (OCT) in children with acquired demyelinating diseases. Methods This is a cross-sectional study of patients seen between 2006–2008 at the Pediatric MS Center of the Jacobs Neurological Institute. Consensus definitions for pediatric demyelinating disease were followed. All children received OCT testing and assessment of visual acuity (VA) using Snellen and low contrast letter acuity (LCLA) charts. Results Thirty-eight children diagnosed with acquired demyelinating disease, 15 healthy controls, and five children with other neurological disorders (OND) were included. Average RNFLT in healthy controls was 107 ± 12 µm(n = 30) versus 108 ± 5 µm (n = 10) in OND controls. In children with multiple sclerosis, average RNFLT ± SD was 99 ± 14 µm in unaffected (n = 24) versus 83 ± 12 µmin eyes affected by optic neuritis ("affected eyes") (n = 10). Average RNFLT in children with acute disseminated encephalomyelitis and transverse myelitis was 102 ± 15 µm in unaffected (n = 18) versus 67 ± 17 µm in affected eyes (n = 6). In children with optic neuritis (ON), average RNFLT ± SD was 97 ± 13 µm in unaffected (n = 5) versus 89 ± 12 µm in affected eyes (n = 9). Differences between children with demyelinating disease and controls and between ON and nonON eyes were statistically significant (P < 0.001). Bivariate correlations of RNFLT with LCLA (P = 0.002) and VA (P < 0.001) were significant. Conclusions OCT may be a valuable tool for the assessment and monitoring of anterior optic pathway dysfunction in children with demyelinating diseases.
Key Words: acute disseminated encephalomyelitis low contrast letter acuity multiple sclerosis optical coherence tomography
This version was published on July
1, 2009 Multiple Sclerosis, Vol. 15, No. 7,
802-810 (2009) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||